Home EssilorLuxottica, Alcon, MiRXES, and WaisTec Unveil Innovative Medical Devices at CIIE 2025

EssilorLuxottica, Alcon, MiRXES, and WaisTec Unveil Innovative Medical Devices at CIIE 2025

Nov 10, 2025 20:25 CST Updated 20:25
Essilor

Lens Product Design and Manufacturer

Image

On November 10, at the 8th China International Import Expo, multinational medical device companies brought several heavy-weight new products that have just been launched or are about to be launched. Jian Shi Jun is on-site to bring you direct coverage of the new products.


Essilor


Essilor showcased the all-new Stellest™ 2.0 lenses.Stellest™ lenses are currently the first and only glasses lenses to receive FDA approval for slowing myopia progression. Stellest™ 2.0 lenses inherit their advantages and are equipped with the new H.A.L.T. MAX technology, which can more effectively slow axial elongation.


Globally First ReleasedStellest™ Smart Glasses,It is the brand's first smart glasses specifically designed for children aged 6-12, which can accurately record daily wearing duration and provide insights into wearing patterns to customize personalized myopia management solutions for each child. In addition, Essilor® Stellest™ non-prescription lenses have released their evidence-based solution, validated by two-year clinical research data, showing that their effect in slowing axial elongation has not diminished over time.


Elcon


Alcon Releases Three Products:Clareon PanOptix Pro C+ Pro Series Trifocal and Trifocal Toric Intraocular Lenses, Clareon® AutonoMe New Pneumatic Preloaded Products, and Hydrus Microstent Glaucoma Drainage Device.


The trifocal intraocular lens series, made with the new Clareon material, achieves higher light energy efficiency and provides clear visual quality, covering far, intermediate, and near vision needs; the Hydrus glaucoma stent, as a representative of the new generation of MIGS stents, treats mild to moderate primary open-angle glaucoma and is suitable for patients with coexisting cataracts.


Wanyite


Wanyit broughtLocalized Peritoneal Dialysis Access ProductsDebut: This innovative peritoneal dialysis access solution comes in two versions — the Full Package and the Simplified Package. The Full Package integrates the catheter with a complete set of percutaneous catheterization instruments based on the Seldinger technique, empowering doctors to perform minimally invasive catheter placement with greater ease and facilitating the timely initiation of peritoneal dialysis treatment. The Simplified Package offers catheters in various shapes and lengths, comprehensively meeting the acute and chronic dialysis catheterization needs of both pediatric and adult patients.


The full-package set was successfully approved in October this year, and the simplified package is also expected to be approved in the second quarter of 2026.


Mirui


Miread ExhibitedCore Product: MiXiaoWei® Gastric Cancer Screening Kit.This is the first gastric cancer screening kit to be approved by the pharmaceutical regulatory authority in China, filling a market gap domestically.


According to the introduction, MiXiaoWei® adopts advanced liquid biopsy technology, which only requires a small amount of blood sample to complete the test, significantly reducing the invasiveness and discomfort of traditional gastroscopy screening. It is especially suitable for early screening in large populations.Image


By reporter Li Ao

Editor | Jiang Yun, Jia Ting

Operator | Chenxi


Statement: Original content by Jian Shi Ju, please do not reprint without permission.


Image

China Resources Transfers Pharmaceutical Subsidiary; Shandong Introduces New Rules for Bulk Procurement; Significant Price Drop for GLP-1

Jian Shi Jun Takes You on a Tour of the 2025 CIIE! Leave a Comment to Vote for Your Favorite Nutritional Health Company

Major Price Cuts in the Procurement of Imported Star Hypoglycemic Drugs Release a Billion-Dollar Market

Image
Image
Image